Skip to main content
. 2013 Mar 9;381(9869):805–816. doi: 10.1016/S0140-6736(12)61963-1

Figure 1.

Figure 1

Trial profile, showing the different populations analysed to assess the side-effects and the main effects of continuing tamoxifen to 10 years versus stopping tamoxifen at 5 years

ER=oestrogen receptor. *39 patients were allocated twice in error, but stayed on their original allocation. Excludes 18 patients entered in error (17 with distant recurrence and one without ethics approval).